David Berry

Dr. David Berry


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in Advanced Drug Delivery Reviews
Verified
Journal Article
Open access
DBDavid Berry
David Berry
Jonathan William SteedJonathan William Steed
Jonathan William Steed
As small molecule drugs become harder to develop and less cost effective for patient use, efficient strategies for their property improvement become increasingly important to global health initiatives. Improvements in the physical properties of Active Pharmaceutical Ingredients (APIs), without changes in the covalent chemistry, have long been possible through the application of binary component solids. This was first achieved through the use of pharmaceutical salts, within the last 10-15years with cocrystals and more recently coamorphous systems have also been consciously applied to this problem. In order to rationally discover the best multicomponent phase for drug development, intermolecular interactions need to be considered at all stages of the process. This review highlights the current thinking in this area and the state of the art in: pharmaceutical multicomponent phase design, the intermolecular interactions in these phases, the implications of these interactions on the material properties and the pharmacokinetics in a patient.

11 March 2014 in CrystEngComm
Verified
Journal Article
Closed access
PDF file
NBN. Blagden
N. Blagden
SCSimon Coles
Simon Coles
DBDavid Berry
David Berry
In the pharmaceutical arena it is agreed that co-crystals form a vital part of the solid-state toolbox, allowing the progression of novel compounds through the development pathway to patients and improving properties in older medicines. Sadly though, few co-crystals have made it to the market in the form of a new licensed product. This displays a disconnect between research effort and end product. For some time now it has been possible to determine the formation of co-crystals, by a variety of screening and analytical means; although it is recognised that there will always be phases that sit in the ‘greyer’ area of the salt-co-crystal continuum. It is also possible, with limitations, to predict the formation of co-crystals in silico via energetic and structural considerations. So what are the major hurdles and missing links, and what are the key structural properties we need to study to improve the success rate? This highlight hopes to address these.

25 September 2017 in Crystal Growth & Design
Verified
Journal Article
Closed access
MGMelissa J. Goodwin
Melissa J. Goodwin
BSBenjamin W. Steed
Benjamin W. Steed
DYDmitry S. Yufit
Dmitry S. Yufit
OMOsama M. Musa
Osama M. Musa
DBDavid Berry
David Berry
Jonathan William SteedJonathan William Steed
Jonathan William Steed

26 April 2017 in Crystal Growth & Design
Verified
Journal Article
Closed access
APAndrea Perrin
Andrea Perrin
MGMelissa J. Goodwin
Melissa J. Goodwin
OMOsama M. Musa
Osama M. Musa
DBDavid Berry
David Berry
PCPhilip Corner
Philip Corner
Jonathan William SteedJonathan William Steed
Jonathan William Steed

15 March 2016 in CrystEngComm
Verified
Journal Article
Open access
PDF file
KNKarol Nartowski
Karol Nartowski
YKY. Z. Khimyak
Y. Z. Khimyak
DBDavid Berry
David Berry
It has previously been reported that the caffeine : malonic acid co-crystal system forms spontaneously upon the contact of the two materials, here we explore the mechanism of this formation and control the kinetics to enable us to monitor the conversion.

18 April 2016 in Chemical Communications
Verified
Journal Article
Open access
PDF file
PCPhilip A. Corner
Philip A. Corner
JHJ. Jonathan Harburn
J. Jonathan Harburn
Jonathan William SteedJonathan William Steed
Jonathan William Steed
JMJames F. McCabe
James F. McCabe
DBDavid Berry
David Berry
The highly polymorphic compound ROY was the subject of a co-crystal screen. No co-crystals were found, but the study highlights the potential for future prediction of co-amorphous behaviours by determining an interaction between ROY and pyrogallol.